Wednesday, January 25, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Biodetection

Free Home Flu Test Kits for Flusurvey Participants

by Global Biodefense Staff
November 19, 2014
Flu Survey Nasal Swab for Testing

Flusurvey coordinator Clare Wenham uses the nasal swab kit.

People taking part in this year’s Flusurvey, the UK’s biggest crowd-sourced study of influenza, will for the first time be offered a swab to confirm if their symptoms are caused by a flu virus or not as part of a new collaboration with i-sense.

i-sense is a 5 year interdisciplinary research collaboration in early warning sensing systems for infectious diseases, funded by the Engineering and Physical Sciences Research Council (EPSRC).

Data from social media and internet searches will also be combined with Flusurvey, allowing flu trends to be monitored across the UK more accurately and earlier than ever before.

Flusurvey scientists at the London School of Hygiene & Tropical Medicine will analyze weekly information relating to symptoms, provided in an online questionnaire by participants, to monitor if flu is taking hold over the winter months.

They will team up with Public Health England (PHE) and i-sense to compare this information with the results of swab samples and with ‘big data’ on millions of symptoms reported every day via sources such as Twitter.

Complaints of coughs, colds and flu-like symptoms are a common feature of life at this time of year but not all sniffles are a sign of flu. Verifying cases of a virus through testing is a crucial part of efforts to spot a pandemic flu outbreak with the potential to cause serious illness and death, and Flusurvey data feeds into national surveillance programs.

This year, some participants who sign up at http://www.flusurvey.org.uk will be provided with a self-administered nasal swab, enabling official confirmation and a more accurate picture of flu trends in the UK.

Swabs will be sent to 700 participants of different ages and in different locations, selected to represent the population as a whole. If they report an influenza-like illness in their weekly Flusurvey update, they will use the swab themselves at home and see the results in a matter of minutes – much like a home pregnancy test. They will submit their results via email as well as mailing the test to a PHE laboratory for verification.

The number of positive tests received each week will be compared to figures obtained by GP-based virological sampling run by PHE for the same week.

“Virological swabbing is an exciting development of the Flusurvey project as it is going to allow us to see whether those who report symptoms online actually are suffering from a flu virus or something else entirely,” said the UK Flusurvey’s coordinator, Clare Wenham, Research Fellow in Public Health Engagement at the London School of Hygiene & Tropical Medicine. “This way we can get a much better understanding of the burden of flu at any one time in the UK.”

Image credit: London School of Hygiene & Tropical Medicine

Tags: InfluenzaSOCMED

Related Posts

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions
Pathogens

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
New Material Helps Train First Responders on Biothreats
Biodetection

New Material Helps Train First Responders on Biothreats

January 4, 2023
New Virus Discovered in Swiss Ticks
Biosurveillance

New Virus Discovered in Swiss Ticks

December 7, 2022
NIH Grant Awarded to Study Evolution of Lyme Disease Bacteria in Deer Ticks
Pathogens

NIH Grant Awarded to Study Evolution of Lyme Disease Bacteria in Deer Ticks

December 7, 2022
Load More

Latest News

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
Biodefense Headlines – 24 January 2023

Biodefense Headlines – 24 January 2023

January 24, 2023
Biodefense Headlines – 17 January 2023

Biodefense Headlines – 17 January 2023

January 17, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC